PENILE CANCER: Advanced penile cancer continues to elude systemic therapy

    loading  Checking for direct PDF access through Ovid

Abstract

Treatment options in patients with unresectable advanced penile cancer are limited owing to a lack of large, randomized prospective studies. A recent multicentre trial evaluated the use of gemcitabine plus cisplatin in such patients but the results were disappointing. What is the future of systemic therapy for advanced penile cancer?

Related Topics

    loading  Loading Related Articles